#China #Shenzhen #Diabetes Care #SIBIONICS #AGP Summit

SIBIONICS Successfully Hosts 3rd AGP&DTx Summit in Shenzhen

On May 31, 2025, SIBIONICS proudly hosted the 3rd AGP&DTx Summit in vibrant Shenzhen, China. This pivotal event brought together over 100 global experts in diabetes management, emphasizing the need for innovation and collaboration in revolutionizing diabetes care.

The summit was centered around crucial themes including "Significant Milestones and Future Strategies for Standardizing Nursing Practices in AGP Reports". The sessions provided deep insights into the current landscape and the prospective future of digital diabetes management.

Among the highlights of the forum was the launch of a Continuous Glucose Monitoring (CGM) donation program in partnership with March of Dimes China. This initiative aims to provide free CGM devices to children diagnosed with Type 1 Diabetes, empowering them to manage their condition more effectively.

Parallel Sessions and Key Discussions

Attendees engaged in parallel sessions that delved into clinical solutions for CGM+X, exploring practical implementations of AGP and Digital Therapeutics (DTx) technologies. Key topics included:

• - The pivotal role of CGM in optimizing treatment with new insulin formulations.
• - Recent developments in artificial pancreas systems.

Specialized workshops for nursing professionals allowed participants to explore how CGM can enhance clinical care in real-world settings. Additionally, social media influencers were invited to visit SIBIONICS' production site, where they shared personal experiences and tested the latest CGM products.

“Evolution and Renewal” Exhibition

The event featured an exhibition named “Evolution and Renewal” that traced the history of diabetes management. This showcase highlighted how modern CGM technology enables individuals to lead healthier, more fulfilling lives.

SIBIONICS' Commitment to Global Partnerships

Alongside the summit, SIBIONICS hosted its 2nd Global Partnership Summit, which welcomed international distributors to bolster collaborations and speed up global expansion. This initiative reflects SIBIONICS' commitment to creating sustainable solutions in diabetes care.

Vision for the Future of Diabetes Care

By integrating AGP reporting with cutting-edge CGM innovations, SIBIONICS is paving the way toward a future where diabetes care is not only smarter but also more accessible and efficient. With this dedication, SIBIONICS aims to transform technology into actionable solutions, empowering healthcare professionals, inspiring patients, and envisioning a world where diabetes no longer limits human potential.

About SIBIONICS

Founded in 2015, SIBIONICS is a leading name in the medical device sector, headquartered in Shenzhen and Irvine. The company specializes in biocensor innovations, combining continuous monitoring technology with intelligent algorithms and user-friendly software aimed at enhancing health management. With over 500 employees and 25% dedicated to research and development, SIBIONICS is committed to advancing personalized and data-driven healthcare solutions.